Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Oct 15, 2019

Sanofi opens its first digitally-enabled, continuous manufacturing facility; ushers in next generation of biotech manufacturing

- One of the first digital manufacturing facilities in the world to use continuous, intensified biologics production technology
- Video 1
- Photos 6
Sep 30, 2019

New England Journal of Medicine publishes data showing improved survival with Jevtana® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate cancer

- CARD is a treatment sequencing trial investigating the efficacy and safety of Jevtana versus abiraterone or enzalutamide after disease progression following initial androgen receptor-targeted agent therapy and docetaxel
Sep 20, 2019

The Lancet Publishes Results from Two Positive Phase 3 Trials of Dupixent® (dupilumab) in Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Sep 16, 2019

Sanofi and Abbott partner to integrate glucose sensing and insulin delivery technologies to help change the way diabetes is managed

- Collaboration aims to provide a connected device experience for millions of people living with diabetes using insulin
Aug 28, 2019

U.S. District Court invalidates Amgen patent claims targeting PCSK9

Court rules in favor of Sanofi and Regeneron in ongoing Praluent® (alirocumab) patent litigation

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.